Apollo Hospitals Enterprise Ltd Share Price Today - Apollo Hospitals Enterprise Ltd Stock Price Live NSE/BSE

Apollo Hospitals Enterprise Ltd

NSE: APOLLOHOSP BSE: 508869

₹8097

(3.32%)

Wed, 20 May 2026, 01:55 pm

MTF 5xInvest in Apollo Hospitals Enterprise Ltd with 5x Leverage Buy with MTF

Market Cap1163.92B

PE Ratio64.61

Dividend0.25

Health Services

Hospital/Nursing Management

24.5K

Apollo Hospitals Enterprise Share Price Live Chart

1 Day

(3.32%)

No Result Found

Summary

Market Cap
115401.57
Net Profit
1505.10
P/B
11.61
Sector P/E
0
P/E
65.86
EV/EBITDA
30.50
Debt/Equity (Industry)
0.51
Interest Cover (Industry)
6.16
ROCE (Industry)
17.14
RONW (Industry)
18.45
ROE
19.89
ROCE
17.49
Debt/Equity
0.61
EPS (TTM)
126.33
Dividend Yield
0.16
Book Value
631.88
Interest Cover
5.45

Analysis

all

Pros

Dividends per share have increased over the past 10 years.
Dividends paid are well covered by earnings (3.8x coverage).
Dividends after 3 years are expected to be well covered by earnings (4.5x coverage).
Dividends per share have been stable in the past 10 years.
Apollo Hospitals Enterprise's earnings are expected to grow significantly at over 20% yearly.

Cons

Apollo Hospitals Enterprise's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Apollo Hospitals Enterprise's dividend is below the markets top 25% of dividend payers in India (3.08%).
Cash flow for Apollo Hospitals Enterprise is expected to increase but not above the 50% threshold in 2 years time.
Apollo Hospitals Enterprise's earnings are expected to increase but not above the low risk growth rate next year.
Apollo Hospitals Enterprise is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).

Financials

Ratios

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	28.02	28.02	28.02	29.34	29.34
FII	42.62	43.54	44.20	43.49	42.74
DII	22.76	21.51	21.12	21.34	22.29
Public	6.37	6.71	6.43	5.61	5.41
Government	0.23	0.23	0.23	0.23	0.23

Technical Analysis

RSI

63.02

MACD

128.05

50 DMA

7666.82

200 DMA

7511.19

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	9011.17	8283.17	7959.83	7555.17	7231.83	6827.17	6099.17
Fibonacci	8283.17	8005.07	7833.26	7555.17	7277.07	7105.26	6827.17
Camarilla	7836.70	7769.97	7703.23	7555.17	7569.77	7503.03	7436.30

Pivots Level: Classic

+1456.00

9011.17

+728.00

8283.17

+404.67

7959.83

7555.17

Pivot Point

LTP: 8078.50

-323.33

7231.83

-728

6827.17

-1456

6099.17

Moving Average

SMAEMA

Period

Value

10-EMA
8004.67
20-EMA
7904.55
30-EMA
7827.26
50-EMA
7720.25
100-EMA
7583.93
200-EMA
7445.14

Announcement Date	Purpose	Action	Ex Date
20 May 2026	board-meetings	Accounts, Quarterly Results, Final Dividend
10 Feb 2026	dividend	₹10.00 Dividend /Share	16 Feb 2026
10 Feb 2026	board-meetings	Quarterly Results
16 Jan 2026	dividend	Interim Dividend - Rs. - 10	16 Feb 2026
06 Nov 2025	board-meetings	Quarterly Results, Half Yearly Results
19 Jul 2025	dividend	Final Dividend - Rs. - 10	19 Aug 2025
30 May 2025	agm
30 May 2025	dividend	₹10.00 Dividend /Share	19 Aug 2025
10 Feb 2025	dividend	₹9.00 Dividend /Share	15 Feb 2025
15 Jan 2025	dividend	Interim Dividend - Rs. - 9	15 Feb 2025

Apollo Hospitals Enterprise Ltd

Max Healthcare Institute Ltd

Aster DM Healthcare Ltd

Narayana Hrudayalaya Ltd

Global Health Ltd

Fortis Healthcare Ltd

Apollo Hospitals Enterprise Ltd About

Apollo Hospitals Enterprise The main business of the Company and its subsidiaries (hereinafter referred to as ‘the Group’) is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis and providing / selling high quality pharma and wellness products through a network of pharmacies, including operation of multidisciplinary private hospitals, clinics,diagonostic centers and pharmacies.

Industry

Healthcare

Founded

1979

Headquarters

CEO

Preetha Reddy

Employees

Contact

Website

http://www.apollohospitals.com

investor.relations@apollohospitals.com

Phone

91-44-28290956/28293896

Location

No 19 Bishop Garden, Raja Annamalaipuram, Chennai, Tamil Nadu, 600028

Year	History
2020	Launched Sanjeevani Telehealth Seva for non-COVID patients in Bhopal.
2021	Partnered with Anatomiz3D to establish 3D printing labs across several facilities.
2022	Partnered with Balmer Healthcare to set up tertiary care hospital in Kenya. Launched automated AI-based real-time rapid-response patient monitoring system, Enhanced Connected Care. Performed novel interventional procedures to save four patients with Atrial Fibrillation at Chennai. Performed world's first Endoscopic Transcanal Excision of Facial Nerve Schwannoma at Apollo Cancer Centre, Bangalore.
2023	Approved detailed expansion plan involving capital outlay of Rs. 34,350 million.
2024	Launched Fatty Liver Clinic at Chennai with cutting-edge diagnostic tools and pharmacological treatments. Apollo Proton Cancer Centre trained international doctors for Proton Beam Therapy in collaboration with Belgium-based IBA. Apollo Proton Cancer Centre unveiled India's first integrated organ and disease-specific programme for rectal cancer management. Apollo Cancer Centres launched Unmask Cancer initiative to tackle societal biases against cancer patients and survivors. Apollo Cancer Centre introduced India's fastest and most precise breast cancer diagnosis program.

Client Name	Deal Type	Order Side	QTY	Avg Price	Date
KADENSA MASTER FUND	block	Buy	59584	7312	19 Nov 2025
BOFA SECURITIES EUROPE SA	block	Sell	59584	7312	19 Nov 2025
GOLDMAN SACHS BANK EUROPESE-ODI	block	Sell	92363	7474	10 Nov 2025
BOFA SECURITIES EUROPE SA	block	Buy	92363	7474	10 Nov 2025
GOLDMAN SACHS BANK EUROPE SE - ODI	block	Buy	52098	7852.5	17 Sept 2025
GOLDMAN SACHS (SINGAPORE) PTE - ODI	block	Sell	52098	7852.5	17 Sept 2025
GOLDMAN SACHS (SINGAPORE) PTE - ODI	block	Sell	40265	7874.5	15 Sept 2025
GOLDMAN SACHS BANK EUROPE SE - ODI	block	Buy	40265	7874.5	15 Sept 2025
GOLDMAN SACHS BANK EUROPE SE - ODI	block	Buy	43031	7786.5	09 Sept 2025
GOLDMAN SACHS (SINGAPORE) PTE - ODI	block	Sell	43031	7786.5	09 Sept 2025

Apollo Hospitals Enterprise Ltd News

Apollo Hospitals to Host Q4 FY26 Earnings Call on May 21

Apollo Hospitals Enterprise Ltd. has scheduled a conference call for analysts and investors on May 21, 2026, at 3:00 PM IST to discuss Q4 FY26 audited financial results.

16 May 2026

companies

Apollo Hospitals: ₹35.22 Cr Block Trade on NSE

Apollo Hospitals Enterprise Ltd. recorded a block trade on NSE worth ₹35.22 crores, involving approximately 43,646 shares at a price of ₹8068.50 per share.

15 May 2026

equity-markets

Apollo Hospitals Gets NCLT Order on Composite Scheme

Apollo Hospitals received the certified true copy of the NCLT order dated May 5, 2026, related to a composite scheme of arrangement involving Apollo Healthco, Keimed, and Apollo Healthtech.

08 May 2026

companies

Apollo Hospitals Gets NCLT Order on Composite Scheme

Apollo Hospitals received the certified true copy of the NCLT order dated May 5, 2026, related to a composite scheme of arrangement involving Apollo Healthco, Keimed, and Apollo Healthtech.

08 May 2026

companies

Apollo Hospitals Records ₹40.52 Cr NSE Block Trade

Apollo Hospitals Enterprise Ltd. recorded a block trade on NSE worth ₹40.52 crores, involving approximately 52,208 shares at a price of ₹7761.00 per share.

06 May 2026

equity-markets

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Asset Management Companies

Popular Stocks

Indian Indices

Sector Wise Stocks

IPO

Share Market

Best MF Schemes

Platforms

Resources

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800